Lianhe Chemical TechnologyLtd Past Earnings Performance
Past criteria checks 0/6
Lianhe Chemical TechnologyLtd's earnings have been declining at an average annual rate of -21%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
-21.0%
Earnings growth rate
-22.6%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 9.4% |
| Return on equity | -4.5% |
| Net Margin | -6.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Lianhe Chemical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,783 | -357 | 783 | 261 |
| 30 Jun 24 | 5,755 | -476 | 777 | 290 |
| 31 Mar 24 | 5,950 | -507 | 785 | 340 |
| 31 Dec 23 | 6,442 | -465 | 772 | 372 |
| 30 Sep 23 | 6,982 | 279 | 709 | 440 |
| 30 Jun 23 | 7,828 | 517 | 758 | 442 |
| 31 Mar 23 | 8,130 | 667 | 732 | 419 |
| 31 Dec 22 | 7,865 | 697 | 793 | 388 |
| 30 Sep 22 | 7,749 | 380 | 775 | 356 |
| 30 Jun 22 | 7,276 | 331 | 747 | 340 |
| 31 Mar 22 | 6,851 | 306 | 774 | 319 |
| 31 Dec 21 | 6,587 | 315 | 774 | 310 |
| 30 Sep 21 | 6,097 | 166 | 754 | 301 |
| 30 Jun 21 | 5,676 | 191 | 778 | 269 |
| 31 Mar 21 | 5,528 | 231 | 813 | 276 |
| 31 Dec 20 | 4,782 | 110 | 809 | 256 |
| 30 Sep 20 | 4,407 | 73 | 900 | 256 |
| 30 Jun 20 | 4,016 | 14 | 923 | 239 |
| 31 Mar 20 | 3,703 | -45 | 915 | 216 |
| 31 Dec 19 | 4,284 | 144 | 832 | 211 |
| 30 Sep 19 | 4,809 | 349 | 766 | 188 |
| 30 Jun 19 | 4,681 | 270 | 664 | 199 |
| 31 Mar 19 | 4,385 | 129 | 677 | 176 |
| 31 Dec 18 | 4,114 | 38 | 650 | 171 |
| 30 Sep 18 | 3,808 | 16 | 578 | 145 |
| 30 Jun 18 | 3,990 | 42 | 569 | 208 |
| 31 Mar 18 | 4,260 | 183 | 586 | 175 |
| 31 Dec 17 | 4,107 | 205 | 624 | 140 |
| 30 Sep 17 | 3,717 | 195 | 733 | 117 |
| 30 Jun 17 | 3,264 | 186 | 760 | 0 |
| 31 Mar 17 | 3,021 | 240 | 716 | 0 |
| 31 Dec 16 | 3,099 | 264 | 695 | 0 |
| 30 Sep 16 | 3,319 | 445 | 695 | 0 |
| 30 Jun 16 | 3,858 | 582 | 715 | 0 |
| 31 Mar 16 | 4,029 | 593 | 725 | 0 |
| 31 Dec 15 | 4,008 | 638 | 733 | 0 |
| 30 Sep 15 | 4,065 | 616 | 709 | 0 |
| 30 Jun 15 | 4,133 | 612 | 704 | 0 |
| 31 Mar 15 | 4,040 | 582 | 670 | 0 |
| 31 Dec 14 | 3,990 | 551 | 639 | 0 |
| 30 Sep 14 | 3,852 | 522 | 639 | 0 |
| 30 Jun 14 | 3,694 | 497 | 594 | 0 |
| 31 Mar 14 | 3,616 | 475 | 555 | 0 |
| 31 Dec 13 | 3,368 | 450 | 545 | 0 |
Quality Earnings: 002250 is currently unprofitable.
Growing Profit Margin: 002250 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002250 is unprofitable, and losses have increased over the past 5 years at a rate of 21% per year.
Accelerating Growth: Unable to compare 002250's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002250 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).
Return on Equity
High ROE: 002250 has a negative Return on Equity (-4.46%), as it is currently unprofitable.